NAVCO Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 1/6
NAVCO Pharmaceuticals has a total shareholder equity of CA$19.9K and total debt of CA$693.6K, which brings its debt-to-equity ratio to 3488.3%. Its total assets and total liabilities are CA$951.3K and CA$931.4K respectively.
Key information
3,488.3%
Debt to equity ratio
CA$693.58k
Debt
| Interest coverage ratio | n/a |
| Cash | CA$11.21k |
| Equity | CA$19.88k |
| Total liabilities | CA$931.44k |
| Total assets | CA$951.32k |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: F0U's short term assets (CA$134.8K) do not cover its short term liabilities (CA$850.9K).
Long Term Liabilities: F0U's short term assets (CA$134.8K) exceed its long term liabilities (CA$80.5K).
Debt to Equity History and Analysis
Debt Level: F0U's net debt to equity ratio (3431.9%) is considered high.
Reducing Debt: Insufficient data to determine if F0U's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: F0U's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if F0U's interest payments on its debt are well covered by EBIT.